DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration

• DOI: 10.1007/s12035-019-01796-2
• Publication Date: 2019-11-07T03:02:47Z
• Authors: Daniel W. Summers; Erin Frey; Lauren J. Walker; Jeffrey Milbrandt; Aaron DiAntonio
• Keywords: Armadillo Domain Proteins; Neurons; 0301 basic medicine; Cell Survival; Axons; Mitochondria; 3. Good health; Cytoskeletal Proteins; Mice; 03 medical and health sciences; Nerve Degeneration; Animals; Nicotinamide-Nucleotide Adenylyltransferase

Axon degeneration is a prominent component of many neurological disorders. Identifying cellular pathways that contribute to axon vulnerability may identify new therapeutic strategies for maintenance of neural circuits. Dual leucine zipper kinase (DLK) is an axonal stress response MAP3K that is chronically activated in several neurodegenerative diseases. Activated DLK transmits an axon injury signal to the neuronal cell body to provoke transcriptional adaptations. However, the consequence of enhanced DLK signaling to axon vulnerability is unknown. We find that stimulating DLK activity predisposes axons to SARM1-dependent degeneration. Activating DLK reduces levels of the axon survival factors NMNAT2 and SCG10, accelerating their loss from severed axons. Moreover, mitochondrial dysfunction independently decreases the levels of NMNAT2 and SCG10 in axons, and in conjunction with DLK activation, leads to a dramatic loss of axonal NMNAT2 and SCG10 and evokes spontaneous axon degeneration. Hence, enhanced DLK activity reduces axon survival factor abundance and renders axons more susceptible to trauma and metabolic insult.